Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Drug maker Lupin on Monday said it has received approval from the US health regulator to market a generic medication for Human Immunodeficiency Virus. The company has received tentative approval from ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in the US market.

The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive first-to-file for this products ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have ...

Lupin also shared that it has received FDA approval for sacubitril and valsartan tablets, 24 mg/26 mg, 49 mg/51 mg and 97 ...

"The tentative approval from the USFDA for our Abacavir, Dolutegravir and Lamivudine Tablets enables us to improve the well-being of pediatric patients with HIV-1, thereby significantly boosting our ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...